The EuroPCR 2022 Conference occurred from May 17 to 20, 2022, in Paris, France. The EuroPCR 2022 combined onsite and online participation seamlessly. Here is our curated list of some of the top highlights from the EuroPCR 2022 Conference presentations. ARCH trial1: Of the 708 patients (N=2,114) with acute coronary syndrome (ACS), post-percutaneous coronary intervention … [Read more...] about EuroPCR 2022 Highlights
Conference coverage
Top Highlights of ACC 2022
The American College of Cardiology (ACC) 2022 Scientific Session was a hybrid event which took place from April 2 to 4, 2022, in Washington, USA and online. Here is the curated list of the top highlights of the ACC 2022 sessions. SODIUM-HF trial1: This international trial (NCT02012179) followed 806 adult patients with chronic heart failure (CHF) receiving optimally … [Read more...] about Top Highlights of ACC 2022
Top Interventional Cardiology Conferences & Courses 2022
Worldwide interventional cardiology conferences and courses offer important learning and networking opportunities in an ever evolving field. Hereby is our curated list (in order, by date) of the top interventional cardiology conferences and courses planned for 2022. Also review the main general cardiology conferences that are listed in our Top Cardiology Conferences 2022. … [Read more...] about Top Interventional Cardiology Conferences & Courses 2022
Top Cardiology Conferences 2022
Looking ahead here is our curated list (in order, by date) of the top cardiology conferences planned for 2022. 19th International Conference on Pediatrics and Pediatric Cardiology May 18-19, 2022 Location: Amsterdam, Netherlands & Online The main focus and theme for the Pediatric Cardiology 2022 conference is “Emerging interventions in Pediatric … [Read more...] about Top Cardiology Conferences 2022
Top 10 Highlights of ESC Congress 2021
The European Society of Cardiology (ESC) 2021 occurred virtually this year from 27-30 August. Here is our curated list of the top 10 highlights of ESC 2021. EMPEROR-Preserved trial1 (NCT03057951): This phase 3 trial randomized 5988 adults with chronic heart failure (HF) with preserved ejection fraction (HFpEF) to take either sodium-glucose cotransporter 2 inhibitor … [Read more...] about Top 10 Highlights of ESC Congress 2021